<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38620899</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2667-0496</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Season>Jan-Mar</Season></PubDate></JournalIssue><Title>Neurology perspectives</Title><ISOAbbreviation>Neurol Perspect</ISOAbbreviation></Journal><ArticleTitle>[Prognosis of patients with COVID-19 presenting acute ischaemic stroke and receiving interventional treatment].</ArticleTitle><Pagination><StartPage>33</StartPage><EndPage>38</EndPage><MedlinePgn>33-38</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neurop.2021.03.007</ELocationID><Abstract><AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">Presentar nuestra experiencia y analizar el pron&#xf3;stico de pacientes COVID-19 con ictus isqu&#xe9;mico agudo por oclusi&#xf3;n de grandes vasos tratados con neurointervencionismo (NIV) en la unidad de ictus.</AbstractText><AbstractText Label="MATERIAL Y M&#xc9;TODOS" NlmCategory="UNASSIGNED">Se incluyeron todos los pacientes consecutivos con ictus isqu&#xe9;mico agudo debido a oclusi&#xf3;n de grandes vasos tratados por NIV en nuestra instituci&#xf3;n entre marzo y abril de 2020, durante el brote de COVID-19. Se realiz&#xf3; una comparaci&#xf3;n entre pacientes con COVID-19 y pacientes sin infecci&#xf3;n por coronavirus. Se comunican los resultados cl&#xed;nicos iniciales y a corto plazo.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">Del 1 de marzo al 30 de abril se realizaron 25 procedimientos de NIV por ictus isqu&#xe9;mico agudo en nuestra instituci&#xf3;n. Ocho pacientes eran COVID-19 y 17 eran pacientes no COVID-19. La edad media de los pacientes con COVID-19 fue de 70,1&#xa0;&#xb1;&#xa0;12,23 a&#xf1;os, y 7 fueron hombres (87,5%, p&#xa0;=&#xa0;0,006). Mientras que todos los pacientes sin COVID proced&#xed;an de urgencias, solo 5 pacientes con COVID-19 (62,5%) fueron atendidos desde urgencias por ictus (p&#xa0;=&#xa0;0,01). Tres pacientes proced&#xed;an de hospitalizaci&#xf3;n. La tasa de mortalidad en pacientes sin COVID-19 fue del 5,8%, pero en pacientes con COVID-19 fue considerablemente alta (50%). Ning&#xfa;n par&#xe1;metro anal&#xed;tico difiri&#xf3; entre ambos grupos. No se registraron hemorragias en esta serie.En comparaci&#xf3;n con el mismo per&#xed;odo del a&#xf1;o pasado, se observ&#xf3; una disminuci&#xf3;n de la actividad neurointervencionista del 39%.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">La mejor terapia m&#xe9;dica y de NIV desemboc&#xf3; en malos resultados y una mortalidad dram&#xe1;tica. La pandemia de COVID-19 dificult&#xf3; significativamente el funcionamiento normal de los servicios de urgencias y la atenci&#xf3;n de estos pacientes con ictus.</AbstractText><CopyrightInformation>&#xa9; 2021 Sociedad Espa&#xf1;ola de Neurolog&#xed;a. Published by Elsevier Espa&#xf1;a, S.L.U.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gonzalez-Fajardo</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Servicio de Cirug&#xed;a Vascular, Hospital Universitario 12 de Octubre, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ansuategui</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Cirug&#xed;a Vascular, Hospital Universitario 12 de Octubre, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibarra</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Servicio de Cirug&#xed;a Vascular, Hospital Universitario 12 de Octubre, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Arbel&#xe1;ez</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Cirug&#xed;a Vascular, Hospital Universitario 12 de Octubre, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Gutierrez</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Cirug&#xed;a Vascular, Hospital Universitario 12 de Octubre, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saura</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unidad de Neurointervencionismo Radiol&#xf3;gico, Hospital Universitario 12 de Octubre, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcena</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unidad de Neurointervencionismo Radiol&#xf3;gico, Hospital Universitario 12 de Octubre, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Pron&#xf3;stico de pacientes COVID-19 con ictus isqu&#xe9;mico y tratamiento neurointervencionista.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neurol Perspect</MedlineTA><NlmUniqueID>9918557088306676</NlmUniqueID><ISSNLinking>2667-0496</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJECTIVE">We report our experience and analyse the prognosis of acute ischaemic stroke due to large vessel occlusion (LVO) in patients with COVID-19 receiving neurointerventional treatment.</AbstractText><AbstractText Label="MATERIAL AND METHODS">The study included all consecutive patients with acute ischaemic stroke due to LVO treated with neurointerventional techniques at our institution in March and April 2020, during the COVID-19 outbreak, and compared patients with and without COVID-19. Baseline and short-term clinical data were reported.</AbstractText><AbstractText Label="RESULTS">From 1 March to 30 April 2020, 25 neurointerventional procedures were performed to treat acute ischaemic stroke due to LVO at our institution. Eight patients had COVID-19 and 17 did not. The mean age (SD) of patients with COVID-19 was 70.1 (12.23) years, and 7 were men (87.5%, <i>P</i>&#xa0;=&#xa0;.006). While all 17 patients without COVID-19 were referred from the emergency department, only 5 (62.5%) COVID-19 patients were treated for stroke at the emergency department (<i>P</i>&#xa0;=&#xa0;.01). Three patients had to be hospitalised. The mortality rate was considerably higher among patients with COVID-19 (50%, vs 5.5% in patients without COVID-19). Both groups presented similar laboratory parameters. No haemorrhages were recorded in this series. We observed a 39% decrease in neurointerventional procedures in comparison with the same period the previous year.</AbstractText><AbstractText Label="CONCLUSIONS">The best medical and neurointerventional treatment resulted in poor outcomes and a dramatic mortality rate. The COVID-19 pandemic significantly disrupted the normal functioning of stroke management in emergency departments.</AbstractText><CopyrightInformation>&#xa9; 2021 Sociedad Espa&#xf1;ola de Neurolog&#xed;a. Published by Elsevier Espa&#xf1;a, S.L.U.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>14</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38620899</ArticleId><ArticleId IdType="pmc">PMC7934670</ArticleId><ArticleId IdType="doi">10.1016/j.neurop.2021.03.007</ArticleId><ArticleId IdType="pii">S2667-0496(21)00010-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iba T., Levy J.H., Warkentin T.E., Thachil J., van der Poll T., Levi M. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019;17:1989&#x2013;1994. doi: 10.1111/jth.14578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14578</ArticleId><ArticleId IdType="pubmed">31410983</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Wang M., Chen S., He Q., Chang J., Hong C., et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: A retrospective case series study. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodigiani C., Iapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T., et al. Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID- 19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9&#x2013;14. doi: 10.1016/j.thromres.2020.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.024</ArticleId><ArticleId IdType="pmc">PMC7177070</ArticleId><ArticleId IdType="pubmed">32353746</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M., et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020;191:148&#x2013;150. doi: 10.1016/j.thromres.2020.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.041</ArticleId><ArticleId IdType="pmc">PMC7192101</ArticleId><ArticleId IdType="pubmed">32381264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Xiao M., Zhang S., Xia P., Cao W., Jiang W., et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020;382:e38. doi: 10.1056/NEJMc2007575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Escalard S., Ma&#xef;er B., Redjem H., Delvoye F., Sol&#xe8;ne H., Smajda S., et al. Treatment of acute ischemic stroke due to large vessel occlusion with COVID-19: Experience from Paris. Stroke. 2020;51:2540&#x2013;2543. doi: 10.1161/STROKEAHA.120.030574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.030574</ArticleId><ArticleId IdType="pmc">PMC7282400</ArticleId><ArticleId IdType="pubmed">32466736</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghi S., Ishida K., Torres J., Mac Grory B., Raz E., Humbert K., et al. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020;51:2002&#x2013;2011. doi: 10.1161/STROKEAHA.120.030335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.030335</ArticleId><ArticleId IdType="pmc">PMC7258764</ArticleId><ArticleId IdType="pubmed">32432996</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y.-K., Goh C., Leow A.S.T., Tambyah P.A., Ang A., Yap E.-S., et al. COVID-19 and ischemic stroke: A systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020;50:587&#x2013;595. doi: 10.1007/s11239-020-02228-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02228-y</ArticleId><ArticleId IdType="pmc">PMC7358286</ArticleId><ArticleId IdType="pubmed">32661757</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system. A review. JAMA Cardiol. 2020;5:831&#x2013;840. doi: 10.1001/jamacardio.2020.1286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1286</ArticleId><ArticleId IdType="pubmed">32219363</ArticleId></ArticleIdList></Reference><Reference><Citation>Baracchini C., Pieroni A., Viaro F., Cianci V., Cattelan A.M., Tiberio I., et al. Acute stroke management pathway during Coronavirus-19 pandemic. Neurol Sci. 2020;41:1003&#x2013;1005. doi: 10.1007/s10072-020-04375-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04375-9</ArticleId><ArticleId IdType="pmc">PMC7141930</ArticleId><ArticleId IdType="pubmed">32270359</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Pardo J., Fuentes B., de Leci&#xf1;ana M.A., Campollo J., Casta&#xf1;o P.C., Ruiz J.C., et al. Acute stroke care during the COVID-19 pandemic. Ictus Madrid Program Recommendations. Neurologia. 2020;35:258&#x2013;263. doi: 10.1016/j.nrl.2020.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2020.04.008</ArticleId><ArticleId IdType="pmc">PMC7180371</ArticleId><ArticleId IdType="pubmed">32364127</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>